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ProstateDopaminergic receptor antagonists may be used as galactagogues because they increase serum prolactin (PRL)
by counteracting the inhibitory inﬂuence of dopamine on PRL secretion. The antipsychotic drug sulpiride (SUL)
is documented to be effective as a galactagogue, but it is transferred through milk to the neonates. The aim of
the present study was to evaluate if maternal exposure to SUL during lactation could disrupt maternal care
and/or male offspring reproductive development. The dams were treated daily (gavage) with SUL 2.5 mg/kg
or 25 mg/kg during lactation. Maternal behavior was analyzed on lactational days 5 and 10. In offspring, repro-
ductive and behavioral parameterswere analyzed at different timepoints. SUL treatment did not impairmaternal
care, but caused testicular damage in male offspring. At postnatal day 90, a reduction in testis weight, volume of
seminiferous tubule and histopathological alterations such as an increased percentage of abnormal seminiferous
tubules were observed. Data shows that maternal exposure to SUL during lactationmay impact the reproductive
development of male rats and the testes seem to be the main target organ at adulthood.
© 2013 Elsevier Inc. All rights reserved.1. Introduction
Breast milk production is a complex physiologic process involving
physical and emotional factors and the interaction of multiple hor-
mones. The most important of them is believed to be prolactin (PRL)
[1]. Failure to provide sufﬁcient breast milk in the ﬁrst few postpartum
days is a major cause of breastfeeding failure [2]. Because of this, both
mothers and physicians have sought drugs to address this concern [1].
The available galactagogues are dopaminergic antagonists, which in-
crease serumPRL by counteracting the inhibitory inﬂuence of dopamine
(DA) on PRL secretion [3].
Sulpiride (SUL) is mainly marketed as an antipsychotic drug and is
reported to selectively antagonize central dopaminergic receptors (D2,al Sciences, State University of
+55 43 3371 4307; fax: +55
ghts reserved.D3 andD4) [4].Moreover, SUL has also been documented as an effective
galactagogue [5–7] but it is important to consider that maternal use
of this drug results in exposure of the progeny. Studies with humans
[3,8,9] and rats [7] reported that SUL is excreted unaltered in milk
[3,6–8,10,11] and, in humans, it is estimated that maternal exposure
to 100 mg/kg of SUL daily would result in an average daily intake of
0.135 mg/kg in infant [11].
DA is involved in both the onset and the maintenance of maternal
care [12–15]. Themain nucleus that regulates this behavior is themedial
preoptic area (MPOA) of hypothalamus [16–18]. Some aspects of thema-
ternal behavior are regulated by themesolimbic dopaminergic system in
this area [18] and disruption of mother–pup interaction was reported
after maternal exposure to dopaminergic antagonist [19,20].
Moreover, in rodents, maternal treatment during lactation with an-
tipsychotic drugs such as risperidone [21] and SUL [7] resulted in neona-
tal hyperprolactinemia in the progeny. It is known that PRL plays an
important role in the regulation of testicular function and participates
in the regulation of growth and normal function of all tissues sensitive
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may impact normal development of the reproductive system.
Based on these considerations, this study was carried out in rats in
order to evaluate ifmaternal exposure to SUL during lactation could dis-
rupt maternal care and/or male offspring's reproductive development.
2. Materials and methods
2.1. Animals and treatment
Male and female Wistar rats (85–90 days) from the colony of the
State University of Londrina (UEL) were used as parental generation.
They were kept in a controlled environment with temperature at
21 ± 2 °C; humidity of 55 ± 5%; 12 h light/dark cycle (lights on at
6:00 a.m.) and had free access to regular lab chow and tap water.
Rats were mated (2 females and 1 male per cage) and gestational
day 0was determined if therewere sperm and estrus phase cells in vag-
inal smears. Dams were divided into three groups (20 dams/group):
– Control group (CON): dams received daily 0.20 ml of distilled water,
by gavage, from post-natal day (PND) 0 to PND 21;
– SUL 2.5 mg group (SUL 2.5): dams received daily 2.5 mg/kg of SUL
(Equilid™, Aventis, Brazil), by gavage, from PND 0 to PND 21;
– SUL 25 mg group (SUL 25): dams received daily 25 mg/kg of SUL
(Equilid™, Aventis, Brazil), by gavage, from PND 0 to PND 21.
The dams were daily treated at 12:00–2:00 p.m. The drug was
dissolved in distilled water immediately prior to the treatment.
In humans, the typical dosage for initiation of lactation is 50 mg 2 to
3 times daily [5,6,10,23], which would correspond to approximately 1.7
to 2.5 mg/kg. To address the possibility that rodents may be less sensi-
tive to drugs than human, we have also chosen to evaluate the dose
of 25 mg/kg, which is 10 times higher than the highest human dose
employed as galactagogue.
At PND 0, all litters were weighed and on PND 1 they were culled to
8 pups. Whenever possible, an equal number of male and female pups
were kept within the litter. Pups were weaned on PND 21 and housed
in groups separated by gender and tests until the evaluations. The litter
was the experimental unit (i.e. onemale pup per litterwas used for each
evaluation at each time point). All animals had free access to water and
regular lab chow (Nuvital™, Nuvilab, Brazil) and all animal procedures
were approved by the UEL Ethics Committee for Animal Research
(CEEA 26/11). The experimental design is represented in Fig. 1.
2.2. Parameters analyzed in dams
2.2.1. Maternal general toxicity
Maternal body weight and food intake were recorded weekly
(PNDs 0, 7, 14 and 21) during lactation. Toxicity signs (e.g. lacrimation,Fig. 1. Diagram of the experimental design. PND: postnatal day; AGD: anogenital distanpiloerection, unusual respiratory pattern and tremors) were evaluated
daily during treatment. On PND 21, dams were submitted to the
open-ﬁeld test [24] with two objectives: 1) to evaluate their behavior
outside the home-cage; 2) to ensure that motor function was not
compromised and would not have interfered with maternal care since
that mesolimbic and striatal dopaminergic pathways inﬂuence motor
function [25]. Brieﬂy, the apparatus consisted of a circular surface of
wood (60 cm of diameter) surrounded by a wall. The surface was
painted white and divided into similar parts. Each animal was placed
individually in the center of the arena and the following variables
were recorded during a 3-min session: ambulation (count of ﬂoor
units entered with the four paws), rearing (count of times that the ani-
mal stood on its hind legs), and grooming (time, in seconds, used for the
animal to groom) [26].
2.2.2. Maternal behavior
To investigate the effects of SUL treatment during lactation on
mother–pup interactions, two types of maternal behavior analyses
were conducted. In experiment 1, pups were removed from their home
cage, returned after 30 min and mother–pup interaction was observed
for 30 min. In experiment 2, undisturbed mother and pup interaction
was recorded for 6 h. The experiment 1 was conducted on PND 5 and
the experiment 2 was conducted on PNDs 5 and 10. PNDs 5 and 10
were chosen because on the early time point (PND 5), lactation costs
less energy and pups have limitedmotor capacitywhereas on the second
time point (PND 10) lactation is more energetically expensive and pups'
motor activity is increased. All maternal behavior analyses were carried
out between 8:00 a.m. and 2:00 p.m.
Experiment 1. Maternal behavior observations after pup removal.
Maternal behavior was evaluated on PND 5 in a subset of dams
(10 dams/group). On the test day, all pups were removed from the
home cage and the nest was destroyed. After 30 min, the pups were
returned to the cage and mother–pup interaction was recorded for
30 min. Latency for retrieval behavior and total time grouping, pup
grooming, self grooming, crouching, off pups (deﬁned as the amount
of time the rat spent without any kind of interaction with pups regard-
less of her position in the cage), and nest building were observed. Full
maternal behavior was scored if dams retrieved all pups to the nest
and nursed them for 3 consecutive minutes. All behavioral analyses
were performed using Etholog software [27].
Experiment 2. Undisturbed mother–pup interaction observations.
Maternal behavior was evaluated on PNDs 5 and 10 in a subset of
dams (10 dams/groups). Mother and litter interactions were recorded
on their home cage for 6 h. Videotaping began at 08:00 a.m. in the
light phase. Behavior was scored every minute during this periodce; CON: distilled water; SUL 2.5: Sulpiride 2.5 mg/kg; SUL 25: Sulpiride 25 mg/kg.
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ior, pup grooming and self-grooming. Total number of observationswas
used to calculate the percentage of observations in self-grooming, pup-
grooming, nursing, and off pups.
2.3. Parameters analyzed in pups
2.3.1. Physical development of pups
Pups' body weights were measured weekly (PNDs 0, 7, 14, 21) dur-
ing lactation. On PNDs 0 and 21, the anogenital distances (AGD, distance
from the anus to the genital tubercle) were obtained through a vernier
caliper. AGD was normalized through its division by the cube root of
body weight. From PND 45, preputial separation of males was veriﬁed
daily and considered as indicators of the sexual maturity onset. These
data are expressed as litter mean.
2.3.2. General activity of pups
Male pups were submitted to behavioral analysis in the open-ﬁeld
on PNDs 35 and 75 according to the methodology described in
Section 2.2.1, to evaluate if motor alterations that could interfere in
the sexual behavior assessment were present after lactational exposure
to SUL. The animals were used only once (i.e. different animals belong-
ing to the same litter were used at each age) and all behavioral tests
were recorded by a video camera, linked to a computer in an adjacent
room. Videos were analyzed blindly to treatment.
2.3.3. Reproductive development in male pups
For the evaluation of male reproductive development, 2 pups (PNDs
90–100) from each litter were used, one for the sexual behavior evalu-
ation and the other one for the sexual organweights, sperm parameters
and testis morphometry.
2.3.4. Collection of tissue and organs
One male rat per litter from each experimental group was eutha-
nized with diethyl ether and the right testis and epididymis, ventral
prostate and seminal vesicle (without the coagulating gland and full of
secretion) were removed and their weights (absolute and relative to
body weight) were determined. The right testis and epididymis were
frozen at −20 °C for sperm counting. The left testis was collected for
histopathological analysis.
2.3.5. Daily sperm production per testis, sperm number and transit time in
the epididymis
Right testis was decapsulated and the caput/corpus and
cauda segments from epididymis were separated (n = 15/group).
Homogenization-resistant testicular spermatids (stage 19 of spermio-
genesis) and sperm in the caput/corpus epididymis and cauda epididy-
mis were assessed as described previously by Robb et al. [28], with
adaptations of Fernandes et al. [29]. Mature spermatids were counted
in a Neubauer chamber (four ﬁelds per animal). To calculate daily
sperm production (DSP) number of spermatids at stage 19 was divided
by 6.1, which is the number of days in one seminiferous cycle when
these spermatids are present in the seminiferous epithelium. Sperm
transit time through the epididymis was determined by dividing the
number of sperm in each segment by the DSP.
2.3.6. Sperm motility and morphology
Immediately after euthanasia, sperm were obtained from the right
vas deferens duct (n = 11–12/group) and diluted in 1 ml of modiﬁed
HTF medium (Human Tubular Fluid, Irvine Scientiﬁc™), pre-warmed
at 34 °C. A 10 μl aliquot was placed in a Makler chamber (Irvine) and
analyzed under a phase-contrast microscope (OSM-223287, Olympus)
at 100× magniﬁcation. One hundred sperm were evaluated per animal
and classiﬁed for motility into: mobile and immotile [30]. With the
aid of a syringe and a needle, sperm were recovered from the left
vas deferens by ﬂushing with 1.0 ml of saline formol (10%). To analyzethe sperm morphologically, smears were prepared on histological
slides that were left to dry for 90 min and 200 spermatozoa per ani-
mal were analyzed in a phase-contrastmicroscope (400×magniﬁcation)
[31]. Morphological abnormalities were classiﬁed into two general
categories: head morphology (without characteristic curvature or
isolated form, i.e., no tail attached) and tail morphology (broken or
isolated i.e., no head attached) [32].
2.3.7. Biometric parameters and histological analysis of testis
The left testis (n = 15/group)was promptly dissected,weighed and
ﬁxed by immersion in Bouin's solution for 24 h before being stocked in
ethanol at 70 °C. Testes were cut into tissue fragments, dehydrated in
increasing concentrations of ethanol, and embedded in parafﬁn. Blocks
were sectioned at 5 μm and stained with hematoxylin–eosin.
For testis morphometry, the average diameter of thirty cross sec-
tions of round sex cord/seminiferous tubules per animal was obtained
in a linear reticule micrometer (OSM-223287, Olympus) coupled to an
ocular microscope with 100× ﬁnal magniﬁcation. The volume densities
of various testicular tissue components were determined by light mi-
croscopy using a 100-intersection grid placed in the ocular of the light
microscope. Thirty ﬁelds chosen randomly (3000 points) were scored
for each animal at 400× magniﬁcation. The volume of each component
of the testis was determined as the product of the volume density and
testis volume. Because the testis density is nearly 1.0 (~1.03–4), for sub-
sequent morphometric calculations the testis weight was considered
equal to testis volume [33]. To obtain a more precise measure of testis
volume the testis capsule (~6.5%) was excluded from the testis weight.
The total length of seminiferous tubule (meters) was obtained by
dividing seminiferous tubule volume by the squared radius (R2) of
the tubule times the π value. Two hundred random tubular sections
per animal in 3 nonconsecutive testis cross-sections were analyzed
(400× magniﬁcation) to determine the percentage of seminiferous
tubules with alterations.
2.3.8. Male sexual behavior
Sexual behavior was observed in adult rat (n = 20/group) during
the dark phase of a reversed light/dark cycle, under dim red light. The
animals were allowed a 15-day period of adaptation to the reversed
light/dark cycle before the beginning of the evaluations. The observa-
tions always started 4 h after the onset of darkness and were recorded
by a video camera, linked to a monitor in an adjacent room. For the
copulatory behavior evaluation, each male was placed into a Plexiglas
cage and, after 5 min, a female in natural estrus was introduced into
the cage. During 30 min, the latencies and numbers of intromissions
and ejaculations were observed as described previously [34]. If a male
did not mount within 10 min, the evaluation was interrupted and re-
peated in another day. If the male failed again in the second evaluation,
it was considered sexually inactive.
2.3.9. Sexual incentive motivation
The same animals evaluated for copulatory behaviorwere submitted
to the sexual incentive motivation test [35]. In this test, a rectangular
arena with 50 × 50 × 100 cm (height × width × length) that presents
two openings that communicate with two small arenas with 25 cm2
was used. The small arenas were diagonally opposed to each other
and the communication with the main arena is closed with wire
mesh. For the test, an estrous female (sexual incentive) was placed in
one of the small arenas and a sexually active male (social incentive)
was placed in the other one. The ﬂoor of the main arena had two
25 cm2 divisions (zones) in front of each small arena opening, named
sexual incentive and social incentive zones, respectively. The ex-
perimental male was placed in the center of the main arena and ob-
served for 20 min. The number of visits and the total time spent
visiting each zone were quantiﬁed, and a preference score was calcu-
lated as (time spent in female zone / total time spent in both incentive
zones) × 100 [35].
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Initially, an exploratory analysis was conducted to evaluate normal
distribution (Shapiro–Wilk test) and homogeneity of variance (Levene's
test) of each variable. Variables that presented normal distribution and
homogeneity of variancewere analyzed byANOVA complementedwith
Bonferroni post hoc test. Conversely, for the other variables Kruskal–
Wallis complemented with Dunn's test were performed. For dams and
pups' weight, food intake, AGD and maternal behavior (undisturbed
mother–pup interaction observations), repeated measures ANOVA
(RMANOVA) was applied with day as the within-subject factor and
treatment as the between-subjects factors. Differences were considered
signiﬁcant if p b 0.05.
3. Results
3.1. Parameters analyzed in dams
3.1.1. Maternal general toxicity
Body weight (Fig. 2A), food intake (Fig. 2B) and general activity in
the open-ﬁeld (data not shown) of dams during lactation were unaf-
fected by SUL treatment (p N 0.05).
3.1.2. Maternal behavior
3.1.2.1. Maternal behavior observations after pup removal. ANOVA indi-
cated lack of treatment effect for all the parameters evaluated, i.e. re-
trieval behavior, total time grouping, pup grooming, self grooming,
crouching, off pups, and nest building (data not shown).
3.1.2.2. Undisturbed mother–pup interaction observations. RMANOVA
showed a signiﬁcant (p b 0.05) effect of lactational day on the percentageFig. 2. Body weight (A) and food intake (B) of dams during lactation. Data are means ± SEM o
25: Sulpiride 25 mg/kg.of observations in nursing [PND 5 (CON: 57.69 ± 3.97; SUL 2.5: 62.22 ±
3.27 and SUL 25: 61.67 ± 3.99)/PND 10 (CON: 53.50 ± 3.05; SUL 2.5:
49.29 ± 4.55 and SUL 25: 52.28 ± 2.04) n = 10 dams/group], with
dams spending more time nursing their offspring on PND 5 than on
PND 10. There was no main effect of treatment, i.e., SUL did not affect
maternal behavior.
3.2. Pups
3.2.1. Physical development of pups
Body weight of pups (Fig. 3) during the ﬁrst three weeks of age
and relative AGD (mm/g1/3) of male pups at birth (CON: 1.69 ± 0.04;
SUL 2.5: 1.71 ± 0.04 and SUL 25: 1.77 ± 0.05) as well as on PND 21
(CON: 16.79 ± 0.32; SUL 2.5: 17.57 ± 0.33 and SUL 25: 17.35 ±
0.31) were not inﬂuenced by SUL exposure (p N 0.05) as indicated
by RMANOVA (n = 20 litters/group).
SUL exposure also did not inﬂuence the day of preputial separation
of males (CON: 48.18 ± 0.49; SUL 2.5: 47.08 ± 0.67 and SUL 25:
46.71 ± 0.48, n = 20 litters/group). No signiﬁcant difference in the
body weight was observed among the groups at the day in which pre-
putial cleavage occurred (data not shown).
3.2.2. Behavioral evaluation of pups
The behaviors (ambulation, rearing and grooming) evaluated in the
open-ﬁeld at PNDs 35 and 75 were not inﬂuenced by exposure to SUL
(data not shown).
3.2.3. Reproductive analysis of adult male offspring
Body weight and reproductive organ/gland weight of adult male
pups are presented in Table 1. ANOVA complemented with Bonferroni
indicated that lactational exposure to SUL 25 increased body weight
in PNDs 90–100, increased absolute weight of prostate and reducedf 20 dams/group. ANOVA p N 0.05. CON: distilled water; SUL 2.5: Sulpiride 2.5 mg/kg; SUL
Fig. 3. Pups' bodyweights during the lactational period. Data aremeans ± SEM of 20 litters/group. ANOVA p N 0.05. CON: distilled water; SUL 2.5: Sulpiride 2.5 mg/kg; SUL 25: Sulpiride
25 mg/kg.
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SUL 2.5 exposure, ANOVA complemented with Bonferroni, indicated a
decrease in relative and absolute weight of testis (p b 0.05) compared
to CON. No statistical difference was observed in the other parameters.
In Table 2, sperm parameters are represented. SUL exposure did not
alter sperm count in either doses (ANOVA, p N 0.05). However, an in-
crease in percentage of abnormal head morphology sperm (ANOVA
complemented with Bonferroni, p b 0.05) and in immotile sperm
(p b 0.05, Kruskal–Wallis complemented with Dunn's test) in the SUL
25 group was observed compared to CON.
Biometric parameters of the testes are presented in Table 3. Kruskal–
Wallis showed no effects of SUL exposure on the diameter and total
length of the seminiferous tubules. On the other hand, Kruskal–Wallis
showed a signiﬁcant (p b 0.05) decrease in volume of seminiferous
tubules in SUL 25-exposed rats and a trend (p b 0.06) towards reduc-
tion in the testicular volume in both doses. The histology of the semi-
niferous epithelium (Fig. 4) showed a signiﬁcant increase (p b 0.05,
Kruskal–Wallis complemented with Dunn's test) in the percentage of
abnormal seminiferous tubules [CON: 0.00 (0.00–1.25); SUL 2.5: 2.00
(1.00–6.00)* and SUL 25: 5.00 (1.25–9.00)*] [% median (1–3 quartile),
n = 15 animals/group]. The main testicular histological alteration
observed in these animals was extensive desquamation of germ cells.
Several seminiferous tubules showed severe immature germ cell loss
in the group exposed to the highest dosage (SUL 25).Table 1
Body weight and wet weight of organs from male rats at PNDs 90–100.
CON (20) SUL 2.5 (20) SUL 25 (20)
Final body weight (g) 385.56 ± 8.00 385.47 ± 6.12 415.06 ± 7.14⁎
Absolute weights (g)
Testis 1.56 ± 0.03 1.45 ± 0.02⁎ 1.52 ± 0.08
Epididymis 0.52 ± 0.02 0.50 ± 0.01 0.54 ± 0.03
Prostate 0.36 ± 0.02 0.34 ± 0.02 0.44 ± 0.03⁎
Full seminal vesicle 0.64 ± 0.02 0.59 ± 0.03 0.65 ± 0.04
Empty seminal vesicle 0.19 ± 0.01 0.18 ± 0.01 0.19 ± 0.01
Relative weights (g/100 g)
Testis 0.41 ± 0.01 0.38 ± 0.01⁎ 0.37 ± 0.02 ⁎
Epididymis 0.14 ± 0.005 0.13 ± 0.003 0.14 ± 0.006
Prostate 0.10 ± 0.01 0.09 ± 0.01 0.11 ± 0.01
Full seminal vesicle 0.17 ± 0.01 0.15 ± 0.01 0.16 ± 0.01
Empty seminal vesicle 0.05 ± 0.002 0.05 ± 0.003 0.05 ± 0.003
Data are means ± SEM. Numbers in parentheses represent the number of animals/group.
CON: distilled water; SUL 2.5: Sulpiride 2.5 mg/kg; SUL 25: Sulpiride 25 mg/kg.
⁎ p b 0.05 compared to CON (ANOVA complemented with Bonferroni).Neither sexual behavior (Table 4) nor sexual motivation (Table 5)
was altered by SUL exposure compared to CON group. Signiﬁcant effects
were observed between the two groups exposed to SUL in the latency
to the ﬁrst ejaculation, number of post-ejaculatory intromissions and
number of ejaculations (Table 4). However, considering that SUL-
exposed groups were not different from CON and the lack of a mono-
tonic dose–response relationship, these results are suggested not to be
biologically relevant.
4. Discussion
This study investigated the effects of lactational exposure to SUL, a
dopaminergic antagonist, in maternal care and reproductive develop-
ment of male pups. In reproductive and developmental toxicity studies,
evaluation of maternal toxicity is critical and the main non-invasive
indicators of maternal toxicity are the bodyweight gain and food intake
[36]. In our study, SUL did not alter weight and food intake in dams
during lactation. Although increased body weight was described in
non-pregnant female rats [37,38], we believe that the lack of SUL-
induced increase in body weight observed in this study with lactating
dams is explained by the tremendous energy investment during lacta-
tion [39].
Mesolimbic and striatal dopaminergic pathways are thought to
inﬂuence motor function such that DA receptor agonists stimulate and
antagonists inhibit motor activity [25]. Although SUL is less potent
than other antipsychotics such as haloperidol in inhibiting motor func-
tion [40], we decided to evaluate this parameter in dams as a biomarker
of effect as well as a biomarker of general toxicity. The open ﬁeld test
showed that SUL treatment during lactation did not inﬂuence motor
activity of dams at the end of lactation (PND 21). In the literature,
SUL-induced motor function alterations only with higher doses (from
40 mg/kg) of SUL administered acutely to adult male rats are described
[41,42].
Regarding maternal behavior in rat, its regulation occurs in two
phases: onset, that occurs at parturition and is controlled by several
pregnancy-related hormones (estrogen, progesterone, prolactin and
oxytocin); and maintenance, that occurs during the postpartum period
and is controlled primarily by nonhormonal factors (i.e., themultisenso-
ry stimuli provided by pups) [19]. Studies report that DA is involved
in both the onset and the maintenance of maternal care [12–15]. In
this study, SUL treatment during lactation did not impair mother–pup
interaction and similar results were found with eticlopride, another
D2 antagonist [43], although with different methodology. Other two
studies reported disruption of retrieving after treatment with pimozide
and clepobride, which are also D2 antagonists [19,20]. The lack of
Table 3
Biometric parameters of testis from male rats at PNDs 90–100.
CON (15) SUL 2.5 (15) SUL 25 (15)
Testicular volume (ml) 1.43 (1.37–1.53) 1.37 (1.27–1.48) 1.38 (1.28–1.42)
Volume of seminiferous tubules (ml) 1.12 (1.09–1.16) 1.03 (0.98–1.14) 1.02 (0.96–1.07)*
Diameter of seminiferous tubules (μm) 300.97 (279.89–308.95) 296.32 (287.94–304.40) 294.34 (283.49–305.01)
Total length of seminiferous tubules (m) 15.80 (15.20–17.72) 14.90 (13.60–16.90) 14.40 (12.90–16.95)
Numbers in parentheses represent the number of animals/group. Data are presented as median (1°–3° quartile) and were analyzed by the non-parametric test of Kruskal–Wallis
complemented with Dunn, *p b 0.05. CON: distilled water; SUL 2.5: Sulpiride 2.5 mg/kg; SUL 25: Sulpiride 25 mg/kg.
Fig. 4. Photomicrographs (histopathological analysis) of seminiferous tubule sections of rats from CON group (A) and groups exposed to SUL 2.5 (B and C) and SUL 25 (D), stained by HE.
(A) Seminiferous tubules (TS) with normal aspect show germ cells organized in concentric layers constituting the seminiferous epithelium (arrow), (B and C) desquamation of immature
germ cells (asterisks). (D) Observe the depleted seminiferous epithelium with severe germ cell loss (stars). Scale bars (A, B and D) = 10 μm, C = 50 μm. CON: distilled water; SUL 2.5:
Sulpiride 2.5 mg/kg; SUL 25: Sulpiride 25 mg/kg.
Table 2
Sperm parameters of adult male rats at PNDs 90–100.
Parameters CON SUL 2.5 SUL 25
No. of spermatids (106/testis) 123.63 ± 2.75 113.49 ± 6.11 117.02 ± 7.09
No. of spermatids (106/g/testis) 83.56 ± 2.73 77.77 ± 4.45 79.88 ± 4.37
DSP 20.27 ± 0.45 18.28 ± 1.19 19.18 ± 1.16
No. of spermatozoa × 106/caput + corpus of epididymis 79.56 ± 5.15 76.25 ± 7.52 77.10 ± 9.73
No. of spermatozoa × 106/g/caput + corpus of epididymis 281.39 ± 24.18 286.71 ± 33.40 258.20 ± 28.82
No. of spermatozoa × 106/cauda of epididymis 122.35 ± 8.61 122.33 ± 5.33 121.56 ± 5.55
No. of spermatozoa × 106/g/cauda of epididymis 504.61 ± 38.61 508.16 ± 24.40 483.55 ± 33.11
Sperm transit time (days) through caput/corpus of epididymis 3.97 ± 0.26 4.50 ± 0.42 3.77 ± 0.43
Sperm transit time through cauda of epididymis (days) 6.09 ± 0.46 7.40 ± 0.90 6.60 ± 0.50
Abnormal head morphology sperm (%) 13.59 ± 1.50 15.56 ± 1.77 19.71 ± 1.63*
Mobile sperm (%) 84.00 (81.50–88.50) 75.00 (72.00–78.00) 72.00 (61.00–77.75)*
Immotile sperm (%) 16.00 (11.50–18.50) 25.00 (22.00–28.00) 26.50 (21.50–31.00)*
Data are means ± SEM of 15 animals/group for sperm counts and 11–12 animals/group for sperm morphology and motility. DSP: Daily sperm production. *p b 0.05 compared to CON
(ANOVA complemented with Bonferroni).
Mobile and immotile sperm are presented as median (1°–3° quartile) andwere analyzed by the non-parametric test of Kruskal–Wallis complementedwith Dunn, *p b 0.05 compared to
CON. CON: distilled water; SUL 2.5: Sulpiride 2.5 mg/kg; SUL 25: Sulpiride 25 mg/kg.
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Table 4
Sexual behavior of adult male rats at PNDs 90–100.
Parameters CON SUL 2.5 SUL 25
Latency to the ﬁrst intromission (s) 175.06 ± 30.77 (16/20) 234.12 ± 32.33 (17/20) 146.82 ± 24.94 (17/20)
No. of intromissions until the ﬁrst ejaculation 17.13 ± 1.58 (16/20) 20.53 ± 2.87 (17/20) 14.24 ± 1.42 (17/20)
Latency to the ﬁrst ejaculation (s) 709.00 ± 80.61 (16/20) 784.76 ± 84.11 (17/20) 469.80 ± 48.16 (15/20)#
Latency of the ﬁrst post-ejaculatory intromission (s) 328.64 ± 18.36 (15/20) 336.07 ± 18.25 (15/20) 300.33 ± 20.22 (15/20)
No. of post-ejaculatory intromissions 19.57 ± 2.16 (15/20) 14.40 ± 1.65 (15/20) 21.20 ± 1.23 (15/20)#
No. of ejaculations 2.20 ± 0.20 (15/20) 2.00 ± 0.15 (17/20) 2.73 ± 0.18 (15/20)#
Data are means ± SEM with the number of animals that displayed the behavior per total number of animals in the group given in parenthesis (p b 0.05, ANOVA completed with
Bonferroni). #p b 0.05 compared to SUL 2.5. CON: distilled water; SUL 2.5: Sulpiride 2.5 mg/kg; SUL 25: Sulpiride 25 mg/kg.
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factors. First, pimozide also acts as an opioidergic receptor antagonist
[44] and since the opioidergic system plays a role in maternal behavior
[45], one could not assure that the disruption was attributed to the
dopaminergic antagonism. Second, the different methodologies were
employed, which mother and pups remained separated for a shorter
period (15 min) [19,20] than the one used in this study (30 min).
Since the longer the dam is separated from its pups themoremotivated
she becomes, longer periods of separationmay overcome retrievingdef-
icits [14,20].
Regarding pup evaluation, maternal exposure to SUL increased body
weight of male offspring on PND 90 (highest dose), decreased both
absolute (lowest dose) and relative (both doses) weights of testis,
increased prostate absolute weight (highest dose), increased both the
percentage of abnormal head morphology and the immobile sperm
(highest dose), and decreased volume of seminiferous tubules in the
testis (highest dose). Sperm production as well as motor and sexual
behaviors were not inﬂuenced.
Persistent increased bodyweight has been described after SUL treat-
ment of prepuberal [46] but not adult male rats [47]. Even though the
authors discuss that this is an age-dependent effect in which gonadal
steroids might be involved [46] the mechanism involved in SUL-
induced weight gain after developmental exposure has not been inves-
tigated so far.
Among the parameters used in the evaluation of chemical risks to
the male reproductive apparatus, is the determination of absolute and
relative weights of endocrine organs/glands such as testes, epididymis,
pituitary, seminal vesicle and prostate [48]. In the present study, the
absolute weight of ventral prostate was increased by the highest dose
of SUL but this increase was not detected when considering its relative
weight. Since animals exposed to the highest dose of SUL presented in-
creased body weight, one could infer that heavier animals presented
heavier prostate absolute weight. However, it is noteworthy that if
this was the case, other absolute organs/gland weights might have
been increased as well, which did not happen. Moreover, increased
prostate weights were described in male adults treated with SUL [49]
and metoclopramide [50], another D2 antagonist. The authors sug-
gested that hyperprolactinemia played a major role in this effect, sinceTable 5
Sexual incentive motivation test in male rats at PNDs 90–100.
CON (20) SUL 2.5 (20) SUL 25 (20)
Time spent in male
zone (s)
237.25 ± 27.88 299.75 ± 39.27 300.25 ± 24.21
Time spent in female
zone (s)
568.20 ± 45.70 489.15 ± 41.61 516.60 ± 39.62
Number of visits in
male zone
16.95 ± 1.40 19.15 ± 1.36 18.75 ± 1.26
Number of visits in
female zone
20.75 ± 1.45 20.40 ± 1.20 20.00 ± 1.33
Preference score (%) 0.69 (61.51–84.76) 0.62 (54.76–76.66) 0.62 (55.67–73.50)
Numbers in parentheses represent the number of animals/group. Data are means ± SEM.
ANOVA, p N 0.05. Preference score is presented as median (1°–3° quartile) and was ana-
lyzed by the non-parametric test of Kruskal–Wallis. CON: distilled water; SUL 2.5: Sulpiride
2.5 mg/kg; SUL 25: Sulpiride 25 mg/kg.PRL is important in the regulation of normal growth and development
of prostate, mainly in immature animals [51], acting as a local growth
factor for the prostatic epithelium [52].
In the current study, testicular damage after SUL exposurewas dem-
onstrated by different parameters evaluated (reduced absolute weight
and the volume of seminiferous tubules, negative inﬂuence on sperm
parameters). PRL plays an important role in the regulation of testicular
function in rodents [22] and humans [53] by affecting gonadotropin-
releasing hormone (GnRH) output and, consequently modulating
the luteinizing hormone (LH) released by the pituitary [54]. In rats,
increased PRL levels are often associatedwith regression of the seminif-
erous epithelium [21,22], deformity of spermatozoa [55] and decrease
in the epididymal sperm motility [56]. In humans, hyperprolactinemia
affects seminal ﬂuid quality causing spermiogenic arrest and impair-
ment of sperm motility [57]. Based on these considerations, it is sug-
gested that the testicular damage observed after lactational exposure
to SULmay have resulted from increased PRL levels during reproductive
development due to D2 antagonism induced by SUL. It is interesting
to mention that adult rats [58,59] and humans [60,61] treated with an-
tipsychotics presented hyperprolactinemia with reduced gonadal func-
tion [58–61].
Another explanation to the effects observed in the prostate as well
as in the testis could be a direct action of SUL on the organs/glands.
DA receptors are expressed not only in the pituitary, but also in some
peripheral organs, mainly during the developmental period [62]. D2 re-
ceptors have been found in spermatozoa [63,64], seminiferous tubule
[64] and rat prostate gland [49]. Although the role of these receptors is
unknown [63], their presence indicates that they are a potential target
for drugs [63].
In conclusion, the present study shows that maternal exposure to
SUL during lactation may impact the reproductive development of
male rats and the testes seem to be the main target organ at adulthood.
The necessity of more researches investigating the inﬂuence of SUL and
other galactagogues on the development of reproductive organs/glands
in order to ensure the safety of their use is clear.Conﬂict of interest statement
The authors declare that there are no conﬂicts of interest.Acknowledgments
This work was supported by PROIC/UEL (Scientiﬁc Initiation fellow-
ship AHS and LSS) and CAPES (Master fellowship to MLV).References
[1] Appendix P, Protocol # 9. Use of galactagogues in initiating or augmenting maternal
milk supply. In: Lawrence RA, Lawrence RM, editors. Breastfeeding. A guide for the
medical professional, 7th editionUSA: Elsevier; 2011. p. 1015–9.
[2] Amir LH. Breastfeeding — managing ‘supply’ difﬁculties. Aust Fam Physician
2006;35(9):686–9.
[3] Anderson PO, Valdés V. A critical reviewof pharmaceutical galactagogues. Breastfeed
Med 2007;2(4):229–42.
83M.L. Vieira et al. / Physiology & Behavior 122 (2013) 76–83[4] Mohameda GG, SolimanbMH. Synthesis, spectroscopic and thermal characterization
of sulpiride complexes of iron, manganese, copper, cobalt, nickel, and zinc salts.
Antibacterial and antifungal activity. Spectrochim Acta A 2010;76:341–7.
[5] Gabay MP. Galactogogues: medications that induce lactation. J Hum Lact
2002;18:274–9.
[6] Lasich AJ. Sulpiride and breastfeeding. Afr Med J 2005;95(9):624–6.
[7] Lewis M, Howie PW. Induction of transient hyperprolactinaemia in neonatal rats by
direct or maternal treatment with the dopamine receptor blocker, sulpirida. Acta
Endocrinol 1987;115:357–64.
[8] Aono T, Shioji T, Aki T, Hirota K, Nomura A, Kurachi K. Augmentation of puer-
peral lactation by oral administration of sulpiride. J Clin Endocrinol Metab
1979;48(3):478–82.
[9] Ylikorkala O, Kauppila A, Kivinen S, Viinikka L. Sulpiride improves inadequate lactation.
Br Med J (Clin Res Ed) 1982;285(6337):249–51.
[10] Zuppa AA, Sindico P, Orchi C, Carducci C, Cardiello V, Romagnoli C, et al. Safety and
efﬁcacy of galactogogues: substances that induce, maintain and increase breast milk
production. J Pharm Pharm Sci 2010;13(2):162–74.
[11] Schaefer C. Psychotropic drugs. In: Schaefer C, Peters PWJ, Miller RK, editors. Drugs
during pregnancy and lactation, 2th edition — treatment options and risk assess-
ment. United Kingdom: Academic Press; 2007. p. 708–37.
[12] Bridges RS, DiBiase R, Loundes DD, Doherty PC. Prolactin stimulation of maternal
behavior in female rats. Science 1985;227:782–4.
[13] Bridges RS, NumanM, Ronshein PM, Mann PE, Lupini CE. Central prolactin infusions
stimulate maternal behavior in steroid-treated, nulliparous female rats. Proc Natl
Acad Sci U S A 1990;87(20):8003–7.
[14] Hansen S.Maternal behavior of female ratswith 6-OHDA lesions in the ventral striatum:
characterization of the pup retrieval deﬁcit. Physiol Behav 1994;55:615–20.
[15] Lonstein JS, Simmons DA, Swann JM, Stern JM. Forebrain expression of c-fos due to
active maternal behaviour in lactating rats. Neuroscience 1998;82:267–81.
[16] NumanM, Fleming AS, Levy F. Maternal behavior. In: Neil JD, et al, editor. Knobil and
Neill's physiology of reproduction. 3th edition. USA: Elsevier; 2005. p. 1921–93.
[17] Numan M. Neural basis of maternal behavior in the rat. Psychoneuroendocrinology
1988;13(1–2):47–62.
[18] Stolzenberg DS, Numan M. Hypothalamic interactions with the mesolimbic DA
system in the control of thematernal and sexual behaviors in rats. Neurosci Biobehav
Rev 2011;35(3):826–47.
[19] SilvaMR, BernardiMM, Felicio LF. Effects of dopamine receptor antagonists on ongo-
ing maternal behavior in rats. Pharmacol Biochem Behav 2001;68(3):461–8.
[20] Byrnes EM, Rigero BA, Bridges RS. Dopamine antagonists during parturition disrupt
maternal care and the retention of maternal behavior in rats. Pharmacol Biochem
Behav 2002;73(4):869–75.
[21] Mishra AC, Mohanty B. Lactational exposure to atypical antipsychotic drugs disrupts
the pituitary-testicular axis in mice neonates during post-natal development.
J Psychopharmacol 2010;24(7):1097–104.
[22] Jedlinska M, Rozewiecka L, Ziecik AJ. Effect of hypoprolactinaemia and hyper-
prolactinaemia on LH secretion, endocrine function of testes and structure of semi-
niferous tubules in boars. J Reprod Fertil 1995;103:265–72.
[23] Hallbauer U. Sulpiride (Eglonyl)-use to stimulate lactation. S Afr Med J
1997;87(6):774–5.
[24] Broadhurst PL. Experiments in psychogenetics. In: Eysenk HJ, editor. Experiments in
personality. London: Rutledge and Kegan Paul; 1960. p. 31–61.
[25] O'Connor SE, Brown RA. The pharmacology of sulpiride — a dopamine receptor
antagonist. Gen Pharmacol 1982;13(3):185–93.
[26] Moreira EG, Vassilieff I, Vassilieff VS. Developmental lead exposure: behavioral alter-
ations in the short and long term. Neurotoxicol Teratol 2001;23:489–95.
[27] Ottoni EB. EthoLog 2.2: a tool for the transcription and timing of behavior observa-
tion sessions. Behav Res Methods Instrum Comput 2000;32(3):446–9.
[28] Robb GW, Amann RP, Killian GJ. Daily sperm production and epididymal sperm
reserves of pubertal and adult rats. J Reprod Fertil 1978;54(1):103–7.
[29] Fernandes GS, Arena AC, Fernadez CD, Mercadante A, Barbisan LF, Kempinas WG.
Reproductive effects inmale exposed to diuron. Reprod Toxicol 2007;23(1):106–12.
[30] Perobelli JE, Martinez MF, Franchi CAS, Fernandez CDB, Camargo JLV, KempinasWG.
Decreased sperm motility in rats orally exposed to single or mixed pesticides. J
Toxicol Environ Health A 2010;73(13):991–1002.
[31] Seed J, Chapi RE, Clegg ED, Dostal LA, Foote RE, Hurtt ME, et al. Methods for assessing
sperm motility, morphology, and counts in the rat, rabbit, and dog: a consensus
report. Reprod Toxicol 1996;10(3):237–44.
[32] Filler R. Methods for evaluation of rats epididymal sperm morphology. In: Chapin
RE, Heindel JH, editors. Male reproductive toxicology. San Diego, CA: Academic
Press Inc.; 1993. p. 334–43.
[33] França LR, Godinho CL. Testismorphometry, seminiferous epithelium, cycle length, and
daily sperm production in domestic cats (Felis catus). Biol Reprod 2003;68:1554–61.
[34] Gerardin DCC, Bernardi MM, Moreira EG, Pereira OCM. Neuroendocrine and repro-
ductive aspects of adult male rats exposed neonatally to an antiestrogen. Pharmacol
Biochem Behav 2006;83:618–23.
[35] Agmo A. Lack of opioid or dopaminergic effects on unconditioned sexual incentive
motivation in male rats. Behav Neurosci 2003;117:55–68.
[36] Bacchi AD, Ponte B, VieiraML, De Paula JCC,Mesquita SFP, Gerardin DCC, et al. Devel-
opmental exposure to Passiﬂora incarnata induces behavioral alterations in themale
progeny. Reprod Fertil Dev 2013;25(5):782–9.[37] Baptista T, de Baptista EA, Lalonde J, Plamondon J, Kin NM, Beaulieu S, et al. Compar-
ative effects of the antipsychotics sulpiride and risperidone in female rats on energy
balance, body composition, fat morphology and macronutrient selection. Prog
Neuropsychopharmacol Biol Psychiatry 2004;28(8):1305–11.
[38] Parada MA, Hernandez L, Paez X, Baptista T, Puig de Parada M, de Quijada M. Mecha-
nism of the body weight increase induced by systemic sulpiride. Pharmacol Biochem
Behav 1989;33(1):45–50.
[39] Woodside B, Augustine RA, Ladyman SR, Naef L, Grattan DR. Role of prolactin in the
metabolic adaptations to pregnancy and lactation. In: Bridges RS, editor. Neurobiology
of the parental mind. USA: Elsevier; 2008. p. 249–68.
[40] Costall B, Naylor RJ. Antagonism of the hyperactivity induced by dopamine applied
intracerebrally to the nucleus accumbens septi by typical neuroleptics and by cloza-
pine, sulpiride and thioridazine. Eur J Pharmacol 1976;35:161–8.
[41] Asmakova LS, Kalinina TS, Ostrovskaya RU, Gudasheva TA, Zaitseva NI, Bondarenko
NA, et al. Comparison of antipsychotic activity and discriminative stimulus effects
of the novel acylprolyltyrosine containing compound, GZR-123, and sulpiride.
Pharmacol Biochem Behav 1999;64(2):359–62.
[42] Bruhwyler J, Chleide E, Liégeois JF, Delarge J, Mercier M. Anxiolytic potential of
sulpiride, clozapine and derivatives in the open-ﬁeld test. Pharmacol Biochem
Behav 1990;36(1):57–61.
[43] Numan M, Numan MJ, Pliakou N, Stolzenberg DS, Mullins OJ, Murphy JM, et al. The
effects of D1 or D2 dopamine receptor antagonism in themedial preoptic area, ventral
pallidum, or nucleus accumbens on thematernal retrieval response and other aspects
of maternal behavior in rats. Behav Neurosci 2005;119(6):1588–604.
[44] Friedman JI, Lindenmayer JP, Alcantara F, Bowler S, Parak M, White L, et al. Pimozide
augmentation of clozapine in patients with schizophrenia and schizoaffective
disorder unresponsive to clozapine monotherapy. Neuropsychopharmacology
2011;36(6):1289–95.
[45] Teodorov E, Tomita AT, Banon GP, Gil IG, Bernardi MM, Felício LF. Behavioral effects
of acute stimulation of kappa-opioid receptors during lactation. Pharmacol Biochem
Behav 2008;90(4):534–9.
[46] Baptista T, Parada MA, Murzi E. Puberty modiﬁes sulpiride effects on body weight in
rats. Neurosci Lett 1988;92:161–4.
[47] Baptista T, Parada M, Hernandez L. Long term administration of some antipsychotic
drugs increases bodyweight and feeding in rats. AreD2dopamine receptors involved?
Pharmacol Biochem Behav 1987;27(3):399–405.
[48] Clegg ED, Perreault D, Klinefelter GR. Assessment of male reproductive toxicity.
In: Hayes AW, editor. Principles and methods of toxicology. Philadelphia: Taylor
& Francis; 2001. p. 1263–300.
[49] Sánchez P, Torres JM, Vílchez P, Del Moral RG, Ortega E. Effects of sulpiride on mRNA
levels of steroid 5alpha-reductase isozymes in prostate of adult rats. IUBMB Life
2008;60(1):68–72.
[50] Sánchez P, Torres JM, Castro B, Frías JF, Ortega E. Effects of metoclopramide on
mRNA levels of steroid 5α-reductase isozymes in prostate of adult rats. J Physiol
Biochem 2013;69(1):133–40.
[51] Costello LC, Franklin RB. Effect of prolactin on prostate. Prostate 1994;24:162–6.
[52] Crepin A, Bidaux G, Vanden-Abeele F, Dewailly E, Gofﬁn V, Prevarskaya N, et al.
Prolactin stimulates prostate cell proliferation by increasing endoplasmic reticulum
content due to SERCA 2b over-expression. Biochem J 2007;401:49–55.
[53] Cheung CY. Prolactin suppresses luteinizing hormone secretion and pituitary
responsiveness to luteinizing hormone–releasing hormone by a direct action at
the anterior pituitary. Endocrinology 1983;113:632–8.
[54] Henderson HL, Townsend J, Tortonese DJ. Direct effects of prolactin and dopamine
on the gonadotroph response to GnRH. J Endocrinol 2008;197(2):343–50.
[55] Laszczyńska M, Rózewicka L, Kuchnio M, Piasecka M, Marchlewicz M. Evaluation of
spermatozoa of rat in hyperprolactinaemia induced by metoclopramide. Andrologia
1992;24(2):101–8.
[56] Huang WJ, Wang PS, Yeh JY. The effect of hyperprolactinemia on epididymal sperm
motility in rats. Fertil Steril 2008;90:S313.
[57] De RosaM, Colao A, Di Sarno A, Ferone D, Landi ML, Zarrilli S, et al. Cabergoline treat-
ment rapidly improves gonadal function in hyperprolactinemicmales: a comparison
with bromocriptine. Eur J Endocrinol 1998;138(3):286–93.
[58] Doherty PC, Baum MJ, Todd RB. Effects of chronic hyperprolactinemia on sexual
arousal and erectile function in male rats. Neuroendocrinology 1986;42:368–75.
[59] Zhang X, Zhang Z, Cheng W, Mou X, Reynolds GP. The effect of chronic antipsy-
chotic treatment on sexual behaviour, hormones and organ size in the male rat. J
Psychopharmacol 2007;21(4):428–34.
[60] Yazigi RA, Quintero CH, SalamehWA. Prolactin disorders. Fertil Steril 1997;67:215–25.
[61] Knegtering M, Van der Moolen AE, Castelein S, Kluiter H, Van den Bosch RJ. What
are the effects of antipsychotics on sexual dysfunctions and endocrine functioning?
Psychoneuroendocrinology 2003;28:109–23.
[62] Saifetyarova YY, Sapronova AY, Ugryumov MV. Endocrine function of dopaminergic
neurons of the whole rat brain in ontogeny: control of prolactin secretion. Dokl Biol
Sci 2012;443(6):753–6.
[63] RamírezAR, CastroMA,Angulo C, Ramió L, RiveraMM, TorresM, et al. The presence and
function of dopamine type 2 receptors in boar sperm: a possible role for dopamine in
viability, capacitation, and modulation of spermmotility. Biol Reprod 2009;80:753–61.
[64] Otth C, Torres M, Ramírez A, Fernandez JC, Castro M, Rauch MC, et al. Novel identi-
ﬁcation of peripheral dopaminergic D2 receptor in male germ cells. J Cell Biochem
2007;100(1):141–50.
